Trials / Completed
CompletedNCT01629160
Ventricular Wall Motion Characterization
Characterization of Normal and Abnormal Ventricular Wall Motion
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate feasibility of using new technologies to characterize ventricular wall motion in patients indicated for mapping and ablation procedures. Echo will be performed preoperatively and patients will receive a 1-month followup telephone call.
Conditions
Timeline
- Start date
- 2012-07-01
- Primary completion
- 2014-01-01
- First posted
- 2012-06-27
- Last updated
- 2019-02-04
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01629160. Inclusion in this directory is not an endorsement.